Benzinga's Top Initiations

by Monica Gerson, Benzinga Staff Writer

August 29, 2013 9:04 AM | 1 min read | Make a Comment

Analysts at Jefferies initiated coverage on shares of Stemline Therapeutics

STML

with a “buy” rating. The target price for Stemline Therapeutics is set to $60. Stemline's shares closed at $33.88 yesterday. Longbow initiated coverage on shares of Teradata

TDC

with a “neutral” rating. Teradata's shares closed at $58.92 yesterday. Lazard Capital initiated coverage on shares of ImmunoCellular Therapeutics

IMUC

with a “buy” rating. The target price for ImmunoCellular Therapeutics is set to $5. ImmunoCellular's stock closed at $2.93 yesterday. Analysts at Maxim initiated coverage on shares of MVC Capital

MVC

with a “buy” rating. The target price for MVC Capital is set to $16.50. MVC Capital's shares closed at $12.36 yesterday.

Market News and Data brought to you by Benzinga APIs